NCT06509906 2025-12-18M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)EMD SeronoPhase 1 Terminated3 enrolled
NCT04747470 2024-09-03Study to Assess the Effects of GS-3583 in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Terminated13 enrolled 18 charts
NCT02648711 2020-05-28Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid TumorsLumos PharmaPhase 1 Terminated41 enrolled